Odds are that you know someone who has been diagnosed as autistic or suspects such a diagnosis. The person may be a child, adolescent or adult. In 2016, the Center for Disease Control - Autism and Developmental Disabilities Monitoring (ADDM) Network estimated that autism was diagnosed in 1 of every 68 births. In fact, in that same report, they also warned that this number has been on the rise. For those with severe autism, medicine has not provided many answers. But, this could be changing thanks to cord blood stem cells. . .
UPDATE: Following this special edition of Share the Science with Dr. Michael Chez, he offered to answered additional questions sent to us based on his presentation. Please find these questions and his detailed responses below. We wish to thank Dr. Chez for generously sharing his expertise and taking the time to answer these additional questions.
Read the full list of questions and responses below. Autism: Are we on the verge of a revolution in medicine?
Save the Cord Foundation and WellSky are proud to welcome Michael G. Chez, M.D. for our next edition of Share the Science on December 12th, 2018. Share the Science is a free webinar series focused on the cord blood industry and the latest research in this field. As always, we invite both health professionals and the general public to join us for this unique online educational series.
During his presentation for Share the Science, Dr. Chez present a broad overview of past and current clinical trials applying stem cell therapy to autism spectrum disorders, as well as future therapeutic opportunities. He will explain the theories behind why stem cell therapy may be useful in autism treatment options. He will discuss recent trials using autologous umbilical cord and other stem cell sourced treatments, as well as the results of those trials. He will also look a the risks and safety of, and the limitations found to date in applying, stem cell therapy.
REGISTER now to join us for this one-to-one chat with Dr. Chez. Ask your questions directly to him and get the information you need.
SHARE THE SCIENCE
with Dr. Michael Chez "Stem Cell Therapy in Autism: Experience and Outcomes" Wednesday, December 12, 2018 | 11:00 AM CS
Free online event. Open to the public. Registration required.
RECORDING NOW AVAILABLE
Dr. Michael Chez Answers Your Questions
Post-conference Question / Answer Session
About the Speaker
Dr. Chez is a board-certified child neurologist and fellowship-trained pediatric epileptologist who has pioneered research in epilepsy treatment and epilepsy surgery monitoring, and the use of alternative therapies to treat autism.
Dr. Chez received his medical degree from the Indiana University School of Medicine and served his internship and residency in pediatrics at Johns Hopkins Hospital. He was awarded a fellowship in child neurology at Children's Memorial Hospital in Chicago, a fellowship at the Cleveland Clinic Foundation in Cleveland, and a fellowship in epilepsy at Rush Presbyterian-St. Luke's Medical Center. Dr. Chez has been certified by the American Board of Pediatrics, and the American Board of Psychiatry and Neurology, with special competence in child neurology.
* * *
We wish to thank Dr. Michael Chez for volunteering his time to speak on Share the Science and sharing his valuable insight on cord blood stem cell therapies. We also wish to thank our generous sponsor and partner for this event, WellSky Health, who continue to support cord blood education through our “Share the Science” series.
 Research exploring the use of cord blood derived therapies is growing and Dr. Joanne Kurtzberg is one of the leading pioneers in this field. Learn about these therapies and the potential use of DUOC-1 as well as the encouraging results of Dr. Kurtzberg's research this October at #ShareTheScience LIVE during the AABB 2018 Annual Meeting. This free special session will be brought to you by Save the Cord Foundation thanks to the generous support of WellSky Health (formerly known as Mediware, Inc.). Have we crossed into new territory with cord blood? This year the world celebrates 30 years since the first cord blood transplant was performed. Dr. Joanne Kurtzberg was there. Indeed, Matthew Farrow was her patient. Working together with an international team led by Dr. Eliane Gluckman, the hope was that a cord blood transplant from Matthew's sister would cure him of fanconi anemia. The procedure worked. Thanks to this groundbreaking use of cord blood stem cells, Matthew grew up strong and healthy. Today, he is an adult with his own family. He is living proof that cord blood saves lives. Yet, this milestone procedure opened the door to a multitude of potential uses for cord blood. Today, cord blood is routinely used to treat more than 80 different life-threatening diseases including many blood cancers. We are also seeing exciting research in the use of cord blood stem cells for regenerative medicine. In particular, researchers are beginning to manipulate cord blood and develop cord blood derived therapies. Dr. Kurtzberg is one of the best known researchers in this field working primarily with children suffering from various brain injuries. Her studies in children with selective inborn errors of metabolism have shown that cord blood cells, administered intravenously after myeloablative therapy engraft in the brain. DUOC-01, a cord blood derived cellular therapy that promotes myelination, is undergoing testing to augment standard umbilical cord blood treatment in children with leukodystrophies. Dr. Kurtzberg explains that these observations have led us to hypothesize that cord blood cells might also have efficacy treating patients with acquired brain injuries. Clinical studies to date have been performed to demonstrate safety and efficacy of intravenous infusions of autologous cord blood in babies with hypoxic ischemic encephalopathy, young children with cerebral palsy, congenital hydrocephalus and autism, and adults with acute ischemic stroke. Further development of these therapies using allogeneic cord blood products can provide access to these therapies for all. On October 15th, we invite you to join us for a special session at the AABB 2018 Annual Meeting where we will host Dr. Kurtzberg for a live Share the Science event. At this event, she will speak about her current research and present the latest results from that work. She will highlight how cord blood banking and transplantation is continuing to evolve. She will also speak about the importance of quality for cord blood units and explain why, if not handled properly, poor quality standards could turn hope into disaster. Attendees will learn the latest in new clinical applications and have an opportunity to participate in a question/answer session with Dr. Kurtzberg. Extending Cord Blood to Regenerative Therapies for the Brain Boston Convention Center in room 151 AB | October 15th from 7:00 - 8:15 a.m. ET Event is RSVP only. Admission is free but seating is limited. About the speaker Dr. Joanne Kurtzberg is an internationally renowned expert in pediatric hematology/oncology, pediatric blood and marrow transplant, umbilical cord blood banking and transplant, and novel applications of cord blood in the emerging fields of cellular therapies and regenerative medicine. Over the last two decades, Dr. Kurtzberg has established an internationally known pediatric transplant program; one of the largest unrelated donor cord blood banks, the Carolinas Cord Blood Bank, in the world; and the Julian Robertson Cell and Translational Therapy Program (CT2) at Duke. Dr. Kurtzberg has published more than 300 peer-reviewed papers, multiple chapters, and scientific reviews. She is a member of the American Society of Hematology, the American Association of Blood and Marrow Transplantation, the American Society of Pediatric Hematology/Oncology, the International Society of Cellular Therapies, the Pediatric Blood and Marrow Transplant Consortium (PBMTC), and other organizations. She serves on the Board of the Foundation of Accreditation of Cellular Therapies, Advisory Council of Blood Stem Cell Transplantation to Health and Human Services. Dr. Kurtzberg was awarded a Lifetime Achievement Award from the PBMTC in 2012. * * * We wish to thank Dr. Kurtzberg for volunteering her time to speak on Share the Science and sharing her valuable insight on cord blood derived therapies. We also wish to thank our generous sponsor and partner for this event, WellSky Health (formerly known as Mediware, Inc.), who continue to support cord blood education through our “Share the Science” series.
 Save the Cord Foundation recently interviewed Dr. Charles S. Cox, Jr. about his research using cord blood to potentially treat Traumatic Brain Injury (TBI). According to Medscape, TBI is defined as, “a non-degenerative, non-congenital insult to the brain from an external mechanical force, possibly leading to a permanent or temporary impairment of cognitive, physical, and psychosocial functions, with an associated diminished or altered state of consciousness.” Furthermore, traumaticbraininjury.com explains that TBI can limit the use of certain parts of the body and can alter personality. It can impair thinking, movement, sensation, emotional functioning, and more. In addition, no two-brain injuries are the same and the consequences of each individual brain injury may be extremely different. According to Centers for Disease Control and Prevention, TBI contributes to about 30% of all injury deaths. Every day, 153 people in the United States die from injuries that include TBI. In this short interview, Dr. Cox gives a brief overview of his work. He and his team recently completed their first acute, autologous cell therapy treatment Phase I study for traumatic brain injury in children aged 5-14. The study represents a significant milestone in Dr. Cox’s research focused on potentially treating traumatic brain injury with cord blood. View the interview with Dr. Cox below or via our channel on YouTube.
Want to learn more about cord blood clinical trials?
Citations 1. Dawodu, ,A (2017) Traumatic Brain Injury (TBI) – Definition, Epidemiology, Pathophysiology. Medscape. Retrieved August 1, 2018, from https://emedicine.medscape.com/article/326510-overview 2. Mayo Foundation for Medical Education and Research, (2018) Traumatic Brain Injury. Mayo Clinic. Retrieved August 1, 2018, from http://www.mayoclinic.org/diseases-conditions/traumatic-brain-injury/symptoms-causes/syc-20378557 3. U.S. Department of Health & Human Services, (2017). TBI: Get the Facts. Centers for Disease Control and Prevention. Retrieved August 1, 2018, from https://www.cdc.gov/traumaticbraininjury/get_the_facts.html |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
April 2019
Categories |
RSS Feed
